Free Trial

IGC Pharma (IGC) Institutional Ownership

IGC Pharma logo
$0.30 -0.03 (-8.92%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$0.30 +0.00 (+0.67%)
As of 02/21/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for IGC Pharma (NYSEMKT:IGC)

Current
Institutional Ownership
Percentage
3.87%
Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$228.71K
Number of
Institutional Sellers
(last 12 months)
0
Get IGC Insider Trade Alerts

Want to know when executives and insiders are buying or selling IGC Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

IGC Institutional Buying and Selling by Quarter

IGC Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025 Squarepoint Ops LLC125,966$42K0.0%N/A0.163%
2/14/2025 Northern Trust Corp113,407$38K0.0%+59.7%0.146%
2/12/2025 Geode Capital Management LLC669,685$225K0.0%+19.0%0.865%
11/20/2024 Virtu Financial LLC123,060$53K0.0%+164.7%0.159%
11/16/2024 Geode Capital Management LLC562,969$240K0.0%+31.0%0.744%
10/29/2024 Fullcircle Wealth LLC103,443$42K0.0%N/A0.137%
(Data available from 1/1/2016 forward)

IGC Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of IGC shares?

During the previous two years, the following institutional investors and hedge funds held shares of IGC Pharma shares: Geode Capital Management LLC ($225K), Virtu Financial LLC ($53K), Squarepoint Ops LLC ($42K), and Fullcircle Wealth LLC ($42K), Northern Trust Corp ($38K).Learn more on IGC's institutional investors.

What percentage of IGC Pharma stock is owned by institutional investors?

3.87% of IGC Pharma stock is owned by institutional investors. Learn more on IGC's institutional investor holdings.

Which institutional investors have been buying IGC Pharma stock?

The following institutional investors have purchased IGC Pharma stock in the last 24 months: Geode Capital Management LLC ($239.86K), Squarepoint Ops LLC ($125.97K), Fullcircle Wealth LLC ($103.44K), Virtu Financial LLC ($76.56K), and Northern Trust Corp ($42.38K).

How much institutional buying is happening at IGC Pharma?

Institutional investors have bought a total of 588,210 shares in the last 24 months. This purchase volume represents approximately $228.71K in transactions.



This page (NYSEMKT:IGC) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners